Recurrent Tuberculosis Disease in Singapore
- PMID: 34307732
- PMCID: PMC8297698
- DOI: 10.1093/ofid/ofab340
Recurrent Tuberculosis Disease in Singapore
Abstract
Background: Previously treated (ie, recurrent) tuberculosis (TB) cases account for approximately 7%-8% of incident TB globally and in Singapore. Molecular fingerprinting has enabled the differentiation of these patients into relapsed or reinfection cases.
Methods: Patient demographics, disease characteristics, and treatment information were obtained from the national TB notification registry and TB Control Unit. We performed a retrospective, case-control study to evaluate factors associated with recurrent TB disease in Singapore citizens and permanent residents with culture-positive TB from 2006 to 2013 and who developed a second episode of culture-positive TB up to 2016 using multivariable logistic regression analyses.
Results: Ninety-one cases with culture-positive first and recurrent TB disease episodes were identified. Recurrent TB was associated with age ≥60 years (adjusted odds ratio [aOR], 1.98 [95% confidence interval {CI}, 1.09-3.61), male sex (aOR, 2.29 [95% CI, 1.22-4.51]), having concomitant pulmonary and extrapulmonary TB (aOR, 3.10 [95% CI, 1.59-6.10]) and extrapulmonary TB alone (aOR, 3.82 [95% CI, 1.12-13.31]), and was less likely in non-Malays (aOR, 0.52 [95% CI, .27-.99]). DNA fingerprinting results for both episodes in 49 cases differentiated these into 28 relapsed and 21 reinfection cases. Relapse was associated with having concomitant pulmonary and extrapulmonary TB (aOR, 9.24 [95% CI, 2.50-42.42]) and positive sputum acid-fast bacilli smear (aOR, 3.95 [95% CI, 1.36-13.10]).
Conclusions: Relapse and reinfection contributed to 57% and 43%, respectively, of recurrent TB in Singapore. Our study highlights the underappreciated association of concomitant pulmonary and extrapulmonary TB as a significant risk factor for disease relapse.
Keywords: exogenous reinfection; extrapulmonary; relapse; tuberculosis.
© The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Figures

References
-
- World Health Organization. Global tuberculosis report 2020. Geneva, Switzerland: WHO; 2020.
-
- Naidoo K, Dookie N. Insights into recurrent tuberculosis: relapse versus reinfection and related risk factors. IntechOpen 2018. doi:10.5772/intechopen.73601.
-
- Lambert ML, Hasker E, Van Deun A, et al. . Recurrence in tuberculosis: relapse or reinfection? Lancet Infect Dis 2003; 3:282–7. - PubMed
-
- Verver S, Warren RM, Beyers N, et al. . Rate of reinfection tuberculosis after successful treatment is higher than rate of new tuberculosis. Am J Respir Crit Care Med 2005; 171:1430–5. - PubMed